REGENERON PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 1087843000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-09-30) |
| Status | superseded |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7f8420d8-3c47-4197-a153-ea81abbe14c0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-18-000036Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/cash-and-equivalents/2018-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7f8420d8-3c47-4197-a153-ea81abbe14c0
History
- no predecessors — first report